AVE 33.3% 0.2¢ avecho biotechnology limited

great times, page-18

  1. 5,322 Posts.
    Nothing wrong with Inflated Hope. So I kinda disagree Charch.
    If its plain silly talk about a stock that is light years from commercialisation then yes multi bagger comments are a waste of time. POH last year when it 24 cts was we thought about to enter the clinic for a Phase 3 Oxy Trial- then 3M threw a curve ball and we got parked.

    Fast forward 12 months and POH is now a very very different beast. Multiple products moving into late stage trials (including a Pain Portfolio still growing), 7 streams of income this year, Deal with one of the worlds largest Pharmas ( Novartis Voltaren), Mylan Injectables progressing, USDA trial on Mastitis is a co maker and according to Analysts the prospect of POH being cash positive in 2014 should give comfort to some nervous about another CR. Add in Animal Feeds & Supplements, GNC and the like and you gotta admit this is a very impressive program for any Bio.

    So talk of multi baggers is in this instance underpinned by near term valuations of various projects. I really don't have a problem unless the vals are far fetched. Weve got Bells suggesting 40-80 cts/ RBS Morgans 27 cts and a number of other Brokers providing cover for POH. In the end the market will determine our value based on what we achieve clinically and how Pharma can commercialise our tech. So why not enjoy the journey and dream a little. I certainly will.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.2¢
Change
-0.001(33.3%)
Mkt cap ! $6.338M
Open High Low Value Volume
0.3¢ 0.3¢ 0.2¢ $11.50K 4.335M

Buyers (Bids)

No. Vol. Price($)
63 101422109 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 20872825 7
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.